Akoya Biosciences, Inc.

Rachunek Zysków i Strat





index 0 1 2 3 4 5
Rok finansowy 2019 2020 2021 2022 2023 2024
Przychód (mln) 42 42 55 75 97 82
Przychód Δ r/r 0.0% 0.5% 29.4% 36.3% 29.1% -15.5%
Marża brutto 58.4% 61.0% 62.3% 58.0% 49.9% 58.6%
EBIT (mln) -14 -11 -37 -66 -56 -47
EBIT Δ r/r 0.0% -14.9% 223.9% 77.9% -15.4% -16.6%
EBIT (%) -32.0% -27.1% -67.8% -88.4% -58.0% -57.2%
Koszty finansowe (mln) 2 3 3 5 9 10
EBITDA (mln) -11 -8 -33 -59 -47 -37
EBITDA(%) -25.6% -18.0% -59.9% -79.3% -48.8% -45.5%
Podatek (mln) 0 0 -0 0 0 0
Zysk Netto (mln) -15 -17 -43 -71 -63 -55
Zysk netto Δ r/r 0.0% 13.3% 157.0% 64.5% -10.4% -12.6%
Zysk netto (%) -34.9% -39.4% -78.2% -94.4% -65.5% -67.8%
EPS -0.4 -0.45 -1.15 -1.87 -1.43 -1.12
EPS (rozwodnione) -0.4 -0.45 -1.15 -1.87 -1.43 -1.12
Ilośc akcji (mln) 37 37 37 38 44 49
Ważona ilośc akcji (mln) 37 37 37 38 44 49
Waluta USD USD USD USD USD USD